GEODE CAPITAL MANAGEMENT, LLC

Position in PSTV — Plus Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in PSTV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,065,256

-$9,820,367 QoQ

Shares Held

2,016,314

+43.7% QoQ

Ownership

29.3%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. PSTV ranks #180 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,065,256	2,016,314	+43.7%	Shares	Defined	2026-05-15
2025-12-31	$17,885,623	1,402,794	+72.5%	Shares	Defined	2026-02-09
2025-09-30	$13,825,250	813,250	+1489.1%	Shares	Defined	2025-11-12
2025-06-30	$447,789	51,176	-10.3%	Shares	Defined	2025-08-08
2025-03-31	$1,355,008	57,053	-1.9%	Shares	Defined	2025-05-13
2024-12-31	$1,671,812	58,150	+7.1%	Shares	Defined	2025-02-12
2024-09-30	$1,981,001	54,274	+16.3%	Shares	Defined	2024-11-12
2024-06-30	$1,714,314	46,648	+59.4%	Shares	Defined	2024-08-09
2024-03-31	$1,324,150	29,263	+10.2%	Shares	Defined	2024-05-13
2023-12-31	$1,161,256	26,543	0.0%	Shares	Defined	2024-02-13
2023-09-30	$889,190	26,543	+56.1%	Shares	Defined	2023-11-13
2023-06-30	$858,853	17,007	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.